Top compounds associated with response to TSPY3


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC -0.081 0.03
mRNA RAF265 CTRPv2 pan-cancer AAC -0.088 0.03
mRNA WP1130 CTRPv2 pan-cancer AAC -0.076 0.03
mRNA Bosutinib CTRPv2 pan-cancer AAC -0.074 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.04
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.074 0.04
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.072 0.04
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.073 0.04
mRNA TAE684 CTRPv2 pan-cancer AAC -0.07 0.04
Download CSV